Why GlaxoSmithKline Beats AstraZeneca and Shire
Motley Fool
This Week in Biotech
Motley Fool
AZ arthritis drug may ease symptoms, but not progression
Delaware Online
AstraZeneca's MedImmune unit acquires AlphaCore Pharma
Yahoo/Fly on the Wall
Most Profitable Second Quarter Biotech Stocks
TheStreet.com
- AbbVie
- Achillion
- Aegerion
- Amarin
- Arena Pharmaceuticals
- AstraZeneca
- Aveo Pharmaceutical
- Biogen Idec
- Bristol-Myers Squibb
- Delcath
- Dendreon
- Depomed
- Gilead
- GSK
- Merck
- NewLink Genetics
- Raptor Pharmaceuticals
- Rigel
- Sangamo BioSciences
- Sucampo
- Titan Pharmaceuticals
- Valeant Pharmaceuticals
- Vertex Pharmaceuticals
- Vivus
- Zogenix
AstraZeneca says Pulmicort Respules patent ruled invalid
Yahoo/Fly on the Wall